The SeCore CDx HLA Sequencing System is the first HLA typing test to receive marketing authorization by the FDA for use as a companion diagnostic WEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher ...
Global HLA Typing for Transplant Market · GlobeNewswire Inc. Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity & ...
The HLA typing market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving the growth include the rising demand for organ transplantation, advancements in molecular ...
Immunogenetics experts at The Children's Hospital of Philadelphia (CHOP) have developed a unique laboratory test to characterize the genes that encode HLA molecules. The test relies on faster, more ...
today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The development represents additional ...
March 1, 2011 (Vol. 31, No. 5)Advances in Extractin and Enzymology Open Door for RNA as Alternative to Genomic DNA The Tissue Typing Laboratory tests for compatibility between patients who require an ...
BRANFORD, Conn.--(BUSINESS WIRE)-- 454 Life Sciences, a Roche Company, announced today the launch and immediate availability of the new GS GType HLA Primer Sets for high- and medium-resolution ...
Life's Applied Biosystems™3500 Dx Genetic Analyzer and SeCore® kits constitute first sequence-based system cleared for HLA typing CARLSBAD, Calif., Feb. 11, 2013 /PRNewswire/ -- Life Technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results